Skip to main content
HR 6963 117th Congress House Health

Accelerated Approval Integrity Act of 2022

Introduced: March 7, 2022 Introduced by: Pallone, Frank Democratic · New Jersey See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 8, 2022
Referred to the Subcommittee on Health.
Mar 7, 2022
Referred to the House Committee on Energy and Commerce.
Mar 7, 2022
Introduced in House
 Plain-English summary Congressional Research Service

Accelerated Approval Integrity Act of 2022

This bill establishes requirements relating to postapproval studies for drugs that receive accelerated approval for serious or life-threatening diseases or conditions, such as requiring product sponsors to agree in advance to conduct such studies and terminating product approval if certain benchmarks are not met.

What's happening now March 8, 2022

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2